Skip to main content
Top

Familial Cancer

Issue 1/2009

Content (12 Articles)

The 4154delA mutation carriers in the BRCA1 gene share a common ancestry

Silvija Ozolina, Olga Sinicka, Eriks Jankevics, Inna Inashkina, Jan Lubinski, Bohdan Gorski, Jacek Gronwald, Tatyana Nasedkina, Olga Fedorova, Ludmila Lyubchenko, Laima Tihomirova

Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines

Julia Hall, Susan Gray, Roger A’Hern, Susan Shanley, Maggie Watson, Kathryn Kash, Robert Croyle, Rosalind Eeles

Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry

Bifeng Zhang, James D. Fackenthal, Qun Niu, Dezheng Huo, Walmy E. Sveen, Tiffani DeMarco, Clement A. Adebamowo, Temidayo Ogundiran, Olufunmilayo I. Olopade

Absence of founder BRCA1 and BRCA2 mutations in coetaneous malignant melanoma patients of Ashkenazi origin

Luna Kadouri, Mark Temper, Tal Grenader, Dvorah Abeliovich, Tamar Hamburger, Tamar Peretz, Michal Lotem

Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance

Ferga C. Gleeson, Georgios I. Papachristou, Douglas L. Riegert-Johnson, Anne-Marie Boller, Christopher J. Gostout

The FAP self-concept scale (adult form)

Mary Jane Esplen, Noreen Stuckless, Terri Berk, Kate Butler, Steve Gallinger

Identification of a mutation in exon 27 of the RB1 gene associated with incomplete penetrance retinoblastoma

Diana Mitter, Diane Rushlow, Inga Nowak, Birgit Ansperger-Rescher, Brenda L. Gallie, Dietmar R. Lohmann

Psychosocial impact of Peutz-Jeghers Syndrome

Alice Woo, Amit Sadana, David T. Mauger, Maria J. Baker, Terri Berk, Thomas J. McGarrity

MLPA mutation detection in Argentine HNPCC and FAP families

Laura C. Gomez, Diego M. Marzese, José Adi, Diego Bertani, Jorge Ibarra, Bart Mol, Ivonne Johanna Vos, Gabriela De Marchi, María Roqué

Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population

Mef Nilbert, Friedrik P. Wikman, Thomas V. O. Hansen, Henrik B. Krarup, Torben F. Örntoft, Finn C. Nielsen, Lone Sunde, Anne-Marie Gerdes, Dorthe Cruger, Susanne Timshel, Marie-Louise Bisgaard, Inge Bernstein, Henrik Okkels

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine